Henan Liliang Diamond Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Henan Liliang Diamond has a total shareholder equity of CN¥5.3B and total debt of CN¥599.9M, which brings its debt-to-equity ratio to 11.3%. Its total assets and total liabilities are CN¥6.5B and CN¥1.2B respectively. Henan Liliang Diamond's EBIT is CN¥221.4M making its interest coverage ratio -3.9. It has cash and short-term investments of CN¥3.7B.
Belangrijke informatie
11.3%
Verhouding schuld/eigen vermogen
CN¥599.86m
Schuld
Rente dekkingsratio | -3.9x |
Contant | CN¥3.72b |
Aandelen | CN¥5.31b |
Totaal verplichtingen | CN¥1.20b |
Totaal activa | CN¥6.51b |
Recente financiële gezondheidsupdates
Does Henan Liliang Diamond (SZSE:301071) Have A Healthy Balance Sheet?
Aug 23Henan Liliang Diamond (SZSE:301071) Seems To Use Debt Quite Sensibly
Mar 06Recent updates
A Piece Of The Puzzle Missing From Henan Liliang Diamond Co., Ltd.'s (SZSE:301071) 44% Share Price Climb
Oct 09Henan Liliang Diamond's (SZSE:301071) Returns On Capital Not Reflecting Well On The Business
Sep 26Does Henan Liliang Diamond (SZSE:301071) Have A Healthy Balance Sheet?
Aug 23Here's What's Concerning About Henan Liliang Diamond's (SZSE:301071) Returns On Capital
May 24Why Henan Liliang Diamond's (SZSE:301071) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 29Henan Liliang Diamond (SZSE:301071) Seems To Use Debt Quite Sensibly
Mar 06Analyse van de financiële positie
Kortlopende schulden: 301071's short term assets (CN¥4.5B) exceed its short term liabilities (CN¥825.1M).
Langlopende schulden: 301071's short term assets (CN¥4.5B) exceed its long term liabilities (CN¥374.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 301071 has more cash than its total debt.
Schuld verminderen: 301071's debt to equity ratio has increased from 7.3% to 11.3% over the past 5 years.
Schuldendekking: 301071's debt is well covered by operating cash flow (77%).
Rentedekking: 301071 earns more interest than it pays, so coverage of interest payments is not a concern.